AUSTRALIAN TELETRIAL PROGRAM REACHES SIGNIFICANT MILESTONES IN TRIALS AND PARTICIPANTS From origins in Townsville to being national program across multiple disease states and populations
Filmed in Brisbane & Townsville, Queensland and Darwin, Northern Territory | November 2024
Launched in 2022, the Australian Teletrial Program is an initiative designed to improve access to clinical trials for people living in regional and remote areas of Australia. It uses telemedicine and digital technologies to enable patients to participate in clinical trials without needing to travel long distances to major metropolitan centres, which can often be a barrier to participation for those in rural and isolated locations.
The program connects patients with researchers, medical professionals, and trial coordinators via video consultations and telehealth tools. This allows patients to receive treatment and follow-up care from their local healthcare providers, while still participating in high-quality clinical research.
Key Features of the Australian Teletrial Program:
- Remote Access to Trials: It facilitates the inclusion of patients from regional and remote areas who would otherwise have difficulty accessing clinical trials due to distance or travel constraints.
- Collaboration: The program involves partnerships between local healthcare providers, hospitals, research institutions, and trial sponsors. This collaborative model ensures that patients receive the best care and support throughout the trial process.
- Digital Health Technologies: Telehealth technologies, such as video conferencing, remote monitoring, and digital data collection, are used to manage patient care and ensure compliance with trial protocols.
- Widening Participation: It aims to diversify and increase the representation of regional and rural populations in clinical trials, which is important for trial results to include the broader population.
The Teletrial Program is part of a broader effort to improve the inclusivity and accessibility of medical research across Australia, ensuring that individuals, regardless of their location, have the opportunity to participate in cutting-edge clinical trials.
Recently Australian Health Journal met with Kaye Hewson, Director, Australian Teletrials Program, who spoke about the program’s recent achievements:
- Being a proven program outside of oncology, with clinical specialties such as respiratory, cardiac, diabetes, sexual health, mental health filling a gap in service and equity.
- In regional, rural and remote places, with adults and paediatrics involved in the program, a higher than national average participation rate of clinical trials by First Nations peoples in satellite locations.
- Savings of time, money and distance for those patients to satellite sites.
- Having over a thousand participants in teletrials across the six jurisdictions.
- Established collaborative and supportive mechanism and network around education and training.
Australian Health Journal also spoke with Melanie Poxton, Assistant Director of Nursing at the program’s Queensland Regional Clinical Trials Coordinating Centre (QRCCC) in Townsville University Hospital, North Queensland and Heather Parker, the Northern Territory Australian Teletrial Program Manager with NT Health.
Produced in collaboration with the Australian Teletrial Program.
You Might also like
-
Strategic research investments for health and prosperity
The CEO of Research Australia, Nadia Levin spoke with Australian Health Journal about the following:
– Current medical research and development landscape in Australia
– Investment required to support the Health and Medical Research and Innovation pipeline
– The National Medical Products Industry Plan and its impact on the Australian economy
– The Health and Medical Research WorkforceIn the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
-
Intervention in hearing loss for patients
In her role as an audiologist and trainer, Lauren McNee emphasises the urgency of addressing sudden hearing loss, highlighting the time-sensitive nature of available treatment options. She advises healthcare professionals, including GPs, pharmacists, primary care nurses and specialists, to remain vigilant for subtle signs of hearing loss in their patients. Such signs may include difficulty following prescription guidelines, miscommunication during conversations, or non-verbal cues like a tilt of the head or asking for repetitions.
-
Sharing the same goals in value-based procurement
Value-based procurement (VBP) is a journey, not a sprint. It’s about putting the patient at the centre of quality affordable healthcare through changes in procurement practices for medical technologies. Patient outcomes drive value and sustainability, not just price. The bigger picture indicates that VBP will create system cost saving through benefitting patients, rather than trying to attain the reverse – a win-win outcome.